EMERYVILLE, Calif.--(BUSINESS WIRE)--Dr. Ron Najafi, CEO of NovaBay Pharmaceuticals, Inc. (AMEX: NBY & TSX: NBY, http://www.novabaypharma.com), a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, will present at the 7th Annual BIO Investor Forum. The conference will be held at the Palace Hotel in San Francisco on October 29-31, 2008. NovaBay’s presentation is scheduled for October 30th, 2008, at 3:15PM/PT.
